Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junping Shi

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Alimentary Pharmacology & Therapeutics|May 14, 2025
Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Population-Based Cohort StudyYee Hui Yeo, Yixuan Zhu, Jingli Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
Alterations in DNA Damage Repair Genes in Primary Liver CancerJianzhen Lin, Junping Shi, Honglin Guo, et al.
Redox Biology|January 30, 2026
UFMylation deficiency in hepatocytes activates the KEAP1-NRF2 pathway and contributes to hepatocarcinogenesisQian Liang, Shiwen Xu, Yaoyao Fang, et al.
Aging|January 28, 2020
TPGS-1000 exhibits potent anticancer activity for hepatocellular carcinoma <i>in vitro</i> and <i>in vivo</i>Yidan Chen, Liqin Mo, Xuan Wang, et al.
ILIVER|July 10, 2025
Tenofovir disoproxil fumarate therapy in patients with chronic hepatitis B and advanced fibrosis or compensated cirrhosisHuiying Rao, Jia Shang, Qing Xie, et al.
Cell Reports. Medicine|February 19, 2025
Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled studyYu Song, Wenjing Ni, Minghua Zheng, et al.
Journal of Medical Virology|January 19, 2023
Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg-positive chronic hepatitis BYanhua Tang, Rong Fan, Zhixian Lan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2025
Two-Step Machine Learning Model Enhances Identification of High-Risk Metabolic Dysfunction-Associated Steatotic Liver DiseaseZheng'ao Xu, Yongfen Zhu, Fengjuan Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2026
Impact of Chronic Hepatitis B and Its Clinical Phases on Liver Fibrosis and Cirrhosis in MASLDFajuan Rui, Jing Zhang, Hongshan Li, et al.
Hepatology (Baltimore, Md.)|January 3, 2014
The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled studyJian Sun, Qing Xie, Deming Tan, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Alimentary Pharmacology & Therapeutics|May 14, 2025
Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Population-Based Cohort StudyYee Hui Yeo, Yixuan Zhu, Jingli Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
Alterations in DNA Damage Repair Genes in Primary Liver CancerJianzhen Lin, Junping Shi, Honglin Guo, et al.
Redox Biology|January 30, 2026
UFMylation deficiency in hepatocytes activates the KEAP1-NRF2 pathway and contributes to hepatocarcinogenesisQian Liang, Shiwen Xu, Yaoyao Fang, et al.
Aging|January 28, 2020
TPGS-1000 exhibits potent anticancer activity for hepatocellular carcinoma <i>in vitro</i> and <i>in vivo</i>Yidan Chen, Liqin Mo, Xuan Wang, et al.
ILIVER|July 10, 2025
Tenofovir disoproxil fumarate therapy in patients with chronic hepatitis B and advanced fibrosis or compensated cirrhosisHuiying Rao, Jia Shang, Qing Xie, et al.
Cell Reports. Medicine|February 19, 2025
Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled studyYu Song, Wenjing Ni, Minghua Zheng, et al.
Journal of Medical Virology|January 19, 2023
Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg-positive chronic hepatitis BYanhua Tang, Rong Fan, Zhixian Lan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2025
Two-Step Machine Learning Model Enhances Identification of High-Risk Metabolic Dysfunction-Associated Steatotic Liver DiseaseZheng'ao Xu, Yongfen Zhu, Fengjuan Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2026
Impact of Chronic Hepatitis B and Its Clinical Phases on Liver Fibrosis and Cirrhosis in MASLDFajuan Rui, Jing Zhang, Hongshan Li, et al.
Hepatology (Baltimore, Md.)|January 3, 2014
The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled studyJian Sun, Qing Xie, Deming Tan, et al.
Pageof 18